Vaccinations likely to start next week as J&J’s research stock bridges gap
Up to 500,000 doses are potentially available to SA
10 February 2021 - 11:28
UPDATED 10 February 2021 - 23:18
The government expects to have 80,000 doses of Johnson & Johnson’s (J&J) coronavirus vaccine on hand next week to launch its immunisation drive, it emerged on Wednesday.
The supplies are being drawn from J&J’s research stock, as its vaccine has yet to be approved by regulators and no commercial product is currently available. Up to 500,000 doses are potentially available to SA, a vital bridge until key deals still in play bear fruit. The government has secured 9-million doses of J&J’s vaccine and is in talks for 20-million more, but has not yet signed final agreements...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.